[HTML][HTML] Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to …
…, J Marlet, S Eymieux, H Regue, Q Semanas… - …, 2021 - eurosurveillance.org
We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …
[HTML][HTML] Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France
…, G Destras, R Chalvignac, Q Semanas… - Nature …, 2022 - nature.com
From December 2021-February 2022, an intense and unprecedented co-circulation of
SARS-CoV-2 variants with high genetic diversity raised the question of possible co-infections …
SARS-CoV-2 variants with high genetic diversity raised the question of possible co-infections …
Two-step strategy for the identification of SARS-CoV-2 variants co-occurring with spike deletion H69-V70, Lyon, France, August to December 2020
A Bal, G Destras, A Gaymard, H Regue, Q Semanas… - medRxiv, 2020 - medrxiv.org
The spike deletion H69-V70 (ΔH69/ΔV70) has been recently detected in a SARS-CoV-2
variant under investigation in England (VUI 202012/01) as well as in cluter-5 variant detected …
variant under investigation in England (VUI 202012/01) as well as in cluter-5 variant detected …
[HTML][HTML] The Role of Lebanon in the COVID-19 Butterfly Effect: The B. 1.398 Example
…, MB Ismail, H Mallat, A Berry, G Burfin, Q Semanas… - Viruses, 2022 - mdpi.com
In the present study, we provide a retrospective genomic surveillance of the SARS-CoV-2
pandemic in Lebanon; we newly sequence the viral genomes of 200 nasopharyngeal samples …
pandemic in Lebanon; we newly sequence the viral genomes of 200 nasopharyngeal samples …
Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France
We report the implementation of a two-step strategy for the identification of SARS-CoV-2
variants carrying the spike deletion H69-V70 ({Delta} H69/{Delta} V70). This spike deletion …
variants carrying the spike deletion H69-V70 ({Delta} H69/{Delta} V70). This spike deletion …
[PDF][PDF] We thank Martine Valette and Quentin Semanas for their help and commitment.
XN Zhao, YY Chen, YH Sun, ZS Liu, XF Zhou, D Li… - pdfs.semanticscholar.org
Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China Page 1 New
variants with several spike mutations (20I/501Y.V1) have been associated with increased …
variants with several spike mutations (20I/501Y.V1) have been associated with increased …
Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France (preprint)
We report the implementation of a two-step strategy for the identification of SARS-CoV-2
variants carrying the spike deletion H69-V70 ({Delta} H69/{Delta} V70). This spike deletion …
variants carrying the spike deletion H69-V70 ({Delta} H69/{Delta} V70). This spike deletion …
[HTML][HTML] Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
G Destras, S Assaad, A Bal… - The Lancet …, 2021 - thelancet.com
… We thank laboratory technicians and Quentin Semanas for their active participation and
help with this study. This study was done as part of the global surveillance of influenza viruses …
help with this study. This study was done as part of the global surveillance of influenza viruses …
[PDF][PDF] Clinical and Phylogenetic Influenza Dynamics for the 2019-20 Season in the Global Influenza Hospital Surveillance Network (GIHSN)–pilot study
L Josset, B Lina - researchgate.net
Background The Global Influenza Hospital Surveillance Network (GIHSN) has operated
with the aim of investigating epidemiological and clinical factors related to severe influenza-…
with the aim of investigating epidemiological and clinical factors related to severe influenza-…
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter …
…, D Damotte, D Maucort-Boulch, C Pangault, G Semana… - Leukemia, 2014 - nature.com
The dosage of soluble programmed cell death ligand 1 (sPD-L1) protein in the blood of adults
with cancer has never been performed in a prospective patient cohort. We evaluated the …
with cancer has never been performed in a prospective patient cohort. We evaluated the …